Florida-based e-cigarette manufacturer Bidi Vapor has taken the US Food and Drug Administration (FDA) to court claiming it suffered “continued irreparable harm” from being given a marketing denial order (MDO) for its vaping products – despite the agency having put the company’s application back under review.
A motion for “stay pending review” filed with the US Court of Appeals for the Eleventh Circuit in Atlanta, Georgia claims Bidi faces “immense financial losses” as a result of the MDO issued by the FDA in response to its premarket tobacco product application (PMTA).
...Restricted content. Do you want to read more?
Florida-based e-cigarette manufacturer Bidi Vapor has taken the US Food and Drug Administration (FDA) to court claiming it suffered “continued irreparable harm” from being given a marketing denial order (MDO) for its vaping products – despite the agency having put the company’s application back under review.
A motion for “stay pending review” filed with the US Court of Appeals for the Eleventh Circuit in Atlanta, Georgia claims Bidi faces “immense financial losses” as a result of the MDO issued by the FDA in response to its premarket tobacco product application (PMTA).
...Are you already a subscriber? login here
Need help?
Contact a sales representative right now and don’t wait
Erik Galavis
+34 654 320 547
Email Erik